When to seek medical advice : Contact your healthcare provider if you're not losing at least 5% of your starting weight after 12 weeks at the maintenance dose, as treatment continuation should be reviewed
placebo with therapy, n = 37 (72.5%)), with suicidal ideation, insomnia and anxiety reported most frequently
Have a Personal or Family History of Medullary Thyroid Carcinoma : Studies have linked GLP-1 receptor agonists to thyroid tumors in animal models
This condition, mainly caused by bacterial infections, oxidative stress, alcohol or chronic allergen exposure, and dysbiosis, leads to the development of several pathologic conditions, including obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver cirrhosis, neurodegeneration, cardiovascular diseases, inflammatory bowel disease, celiac disease, irritable bowel syndrome, type 1 diabetes mellitus (T1D), and several autoimmune conditions (Fig